ALCAM and glioblastoma: Similarly, ALCAM was suggested as a BTIC marker as ALCAM was highly expressed in BTICs where it promoted neurosphere formation capacity and tumor growth while also increasing GBM invasion and metastasis to the brain (53, 54).